A Guide to Compehending China's Three Robotics Giants

China’s humanoid robotics sector is undergoing a critical transition from technical conceptualization to commercial verification, with market leaders accelerating efforts to secure mass production capabilities and capital access. While the delay of Tesla's Optimus Gen3 to the first quarter of next year has cooled sentiment in the secondary market, the primary market remains active as domestic startups pivot toward commercialization to validate their valuations.

Agibot has executed a strategic maneuver to open financing channels by acquiring a controlling 66.99% stake in the Shanghai-listed Swancor Advanced Materials as of July 8, 2025. Concurrently, Unitree Robotics has advanced its own capital ambitions, completing its IPO tutoring phase on November 10 with plans to file for a domestic A-share listing by the first half of 2026. These moves highlight an intensifying race among top players to secure funding amidst varying degrees of market skepticism regarding order backlogs.

On the operational front, UBTech Robotics has distinguished itself by demonstrating tangible industrial delivery. On November 12, the company released footage confirming the mass production and handover of hundreds of its Walker S2 units for frontline industrial use. This marks a divergence from the sector’s previous reliance on educational and exhibition scenarios, with UBTech projecting an annual production capacity of 5,000 industrial humanoid robots by 2026.

The industry landscape reveals a dichotomy where capital enthusiasm persists for new entrants, yet secondary market investors are demanding proof of closed-loop commercialization. With technical bottlenecks in robot "brains" still unresolved across the sector, the focus has shifted to execution, with the three major players—Agibot, Unitree, and UBTech—adopting distinct strategies to navigate the "freezing" market sentiment and prove long-term viability.

Divergent Paths to Commercialization

Commercial viability has become the primary metric for valuation, though the quality of order books varies significantly among the three giants.

• UBTech Robotics: Previously viewed as a company focused on proof-of-concepts, UBTech has begun a new commercial cycle with the release of the autonomous battery-swapping Walker S2. Despite Citigroup Inc. downgrading the company's delivery forecasts in July, UBTech has secured over RMB 800 million (US 110 million) in contracts for its Walker series in 2025, including nearly RMB 50 million (US 6.9 million) in delivered orders from the first half. According to Chief Brand Officer Tan Min, the company aims to scale industrial capacity to 10,000 units by 2027.
• Unitree Robotics: Positioning itself as a hardware provider, Unitree generated annual revenue exceeding RMB 1 billion (US$138 million), with bipedal humanoid robots accounting for at least 30% of sales. The company delivered over 1,500 units in 2024 and projects a three-to-fourfold increase in 2025. However, its primary markets remain education, research, and exhibition, rather than industrial application.
• Agibot: The company has announced numerous orders valued in the tens and hundreds of millions, covering scenarios from manufacturing to logistics. However, market reaction to these figures has been muted due to skepticism regarding execution. Currently, Agibot’s industrial deployment remains predominantly focused on wheeled, rather than bipedal, solutions.

Technology Stacks and Bottlenecks

While all three companies claim full-stack technical capabilities, significant barriers remain in achieving true "embodied intelligence."

• UBTech operates with a proprietary stack including "BrainNet 2.0" and "Co-Agent" technology.
• Agibot has deployed a hardware-software architecture featuring its "GO" embodied intelligence model and the "GE" open-source world model platform.
• Unitree focuses heavily on hardware and motion control, acting as a "shovel seller" for the industry while attempting to bridge gaps in AI development.

Despite these advancements, a genuine competitive moat remains elusive across the sector. The "robot brain" remains a critical bottleneck, and no single company has established a definitive technical lead that guarantees long-term dominance.

The Race for Capital Markets

Access to public capital markets has become a strategic priority to sustain cash burn and fund capacity expansion.

• UBTech (HK: 9880): As the first listed humanoid robot company, UBTech has seen volatility since its December 2023 debut. Shares have corrected from a peak of HK328 to HK118.7 as of the November 20 close, capitalizing the company at approximately HK$47.6 billion. The stock is currently stabilizing as commercial deliveries ramp up.
• Agibot: Following its acquisition of Swancor Advanced Materials in July 2025, Agibot completed a share reform on November 10. Swancor announced on November 6 that it would operate independently while developing embodied intelligence businesses, signaling Agibot’s intent to leverage this platform for broader financing.
• Unitree: The company formally initiated its IPO process in July 2025 and is now in the acceptance phase following the completion of tutoring. If successful, Unitree is poised to become the first humanoid robotics firm listed on China’s A-share market.

While listing provides immediate liquidity, the long-term stability of these firms will depend on their ability to convert capital into sustainable mass production, a test UBTech is currently leading with its recent industrial deliveries.